Cognitive resilience in clinical and preclinical Alzheimer’s disease: the Association of Amyloid and Tau Burden on cognitive performance

Brain Imaging and Behavior

Volumn 11, Issue 2, 2017, Pages 383-390

  Rentz, Dorene M ^a   Mormino, Elizabeth C ^a   Papp, Kathryn V ^a   Betensky, Rebecca A ^b   Sperling, Reisa A ^a   Johnson, Keith A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Aging; Amyloid PET imaging; Preclinical Alzheimer s disease; Resilience; Tau PET imaging

Indexed keywords

AMYLOID BETA PROTEIN; PITTSBURGH COMPOUND B; TAU PROTEIN; AMYLOID PROTEIN; BIOLOGICAL MARKER;

AGED; ALZHEIMER DISEASE; ARTICLE; COGNITIVE RESERVE; CONTROLLED STUDY; FEMALE; HUMAN; INTELLIGENCE QUOTIENT; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; PET SCANNER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; ASYMPTOMATIC DISEASE; BRAIN; COGNITION; COGNITIVE DEFECT; DEMENTIA; METABOLISM; PATHOPHYSIOLOGY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; TASK PERFORMANCE;

AGED; ALZHEIMER DISEASE; AMYLOIDOGENIC PROTEINS; ASYMPTOMATIC DISEASES; BIOMARKERS; BRAIN; COGNITION; COGNITIVE DYSFUNCTION; DEMENTIA; FEMALE; HUMANS; MALE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TASK PERFORMANCE AND ANALYSIS; TAU PROTEINS;

EID: 84991096958     PISSN: 19317557     EISSN: 19317565     Source Type: Journal    
DOI: 10.1007/s11682-016-9640-4     Document Type: Article

References (45)

1. Arriagada, P. V., Growdon, J. H., Hedley-White, E. T., & Hyman, B. T. (1992a). Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology, 42, 631–639.
2. Arriagada, P. V., Marzloff, K., & Hyman, B. T. (1992b). Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease. Neurology, 42(9), 1681–1688.
3. Bateman, R. J., Xiong, C., Benzinger, T. L., Fagan, A. M., Goate, A., Fox, N. C., et al. (2012). Clinical and biomarker changes in dominantly inherited Alzheimer's disease. The New England Journal of Medicine, 367(9), 795–804.
4. Bennett, D. A., Wilson, R. S., Schneider, J. A., Evans, D. A., Mendes de Leon, C. F., Arnold, S. E., et al. (2003). Education modifies the relation of AD pathology to level of cognitive function in older persons. Neurology, 60(12), 1909–1915.
5. Bennett, D. A., Wilson, R. S., Boyle, P. A., Buchman, A. S., & Schneider, J. A. (2012). Relation of neuropathology to cognition in persons without cognitive impairment. Annals of Neurology, 72(4), 599–609.
6. Bieliauskas, L. A., Back-Madruga, C., Lindsay, K. L., Wright, E. C., Kronfol, Z., Lok, A. S., et al. (2007). Cognitive reserve and neuropsychological functioning in patients infected with hepatitis C. Journal of the International Neuropsychological Society, 13(4), 687–692.
7. Braak, H., Alafuzoff, I., Arzberger, T., Kretzschmar, H., & Del Tredici, K. (2006). Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathologica, 112(4), 389–404.
8. Chien, D. T., Bahri, S., Szardenings, A. K., Walsh, J. C., Mu, F., Su, M. Y., et al. (2013). Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807. Journal of Alzheimer's Disease, 34(2), 457–468.
9. Delacourte, A., Sergeant, N., Wattez, A., Maurage, C. A., Lebert, F., Pasquier, F., et al. (2002). Tau aggregation in the hippocampal formation: an ageing or a pathological process? Experimental Gerontology, 37(10–11), 1291–1296.
10. Desikan, R. S., Segonne, F., Fischl, B., Quinn, B. T., Dickerson, B. C., Blacker, D., et al. (2006). An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. NeuroImage, 31(3), 968–980.
11. Fischl, B., Salat, D. H., Busa, E., Albert, M., Dieterich, M., Haselgrove, C., et al. (2002). Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron, 33(3), 341–355.
12. Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189–198.
13. Gomperts, S. N., Rentz, D. M., Moran, E., Becker, J. A., Locascio, J. J., Klunk, W. E., et al. (2008). Imaging amyloid deposition in Lewy body diseases. Neurology, 71(12), 903–910.
14. Hardy, J. (2009). The amyloid hypothesis for Alzheimer's disease: a critical reappraisal. Journal of Neurochemistry, 110(4), 1129–1134.
15. Hedden, T., Oh, H., Younger, A. P., & Patel, T. A. (2013). Meta-analysis of amyloid-cognition relations in cognitively normal older adults. Neurology, 80(14), 1341–1348.
16. Jack Jr., C. R., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., et al. (2013). Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurology, 12(2), 207–216.
17. Johnson, K. A., Schultz, A., Betensky, R. A., Becker, J. A., Sepulcre, J., Rentz, D., et al. (2016). Tau positron emission tomographic imaging in aging and early Alzheimer disease. Annals of Neurology, 79(1), 110–119.
18. Katzman, R. (1993). Education and the prevalence of dementia and Alzheimer's disease. Neurology, 43, 13–20.
19. Kemppainen, N. M., Aalto, S., Karrasch, M., Nagren, K., Savisto, N., Oikonen, V., et al. (2008). Cognitive reserve hypothesis: Pittsburgh compound B and fluorodeoxyglucose positron emission tomography in relation to education in mild Alzheimer's disease. Annals of Neurology, 63(1), 112–118.
20. Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., et al. (2004). Imaging brain amyloid in Alzheimer's disease with Pittsburgh compound-B. Annals of Neurology, 55(3), 306–319.
21. Marquie, M., Normandin, M. D., Vanderburg, C. R., Costantino, I. M., Bien, E. A., Rycyna, L. G., et al. (2015). Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue. Annals of Neurology, 78(5), 787–800.
22. McKee, A. C., Cantu, R. C., Nowinski, C. J., Hedley-Whyte, E. T., Gavett, B. E., Budson, A. E., et al. (2009). Chronic traumatic encephalopathy in athletes: progressive tauopathy after repetitive head injury. Journal of Neuropathology and Experimental Neurology, 68(7), 709–735.
23. Morris, J. C. (1993). The clinical dementia rating scale (CDR): current version and scoring rules. Neurology, 43, 2412–2414.
24. Mungas, D., Marshall, S. C., Weldon, M., Haan, M., & Reed, B. R. (1996). Age and education correction of mini-mental state examination for English and Spanish-speaking elderly. Neurology, 46(3), 700–706.
25. Nelson, P. T., Alafuzoff, I., Bigio, E. H., Bouras, C., Braak, H., Cairns, N. J., et al. (2012). Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. Journal of Neuropathology and Experimental Neurology, 71(5), 362–381.
26. Price, J. L., & Morris, J. C. (1999). Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease. Annals of Neurology, 45(3), 358–368.
27. Rentz, D.M., Huh, T.J., Sardinha, L.M., Moran, E.K., Becker, J.A., Daffner, K.A., et al. (2007). Intelligence quotient-adjusted memory impairment is associated with abnormal single photon emission computed tomography perfusion. Journal International Neuropsychological Society 13(5): 821–31.
28. Rentz, D. M., Locascio, J. J., Becker, J. A., Moran, E. K., Eng, E., Buckner, R. L., et al. (2010). Cognition, reserve, and amyloid deposition in normal aging. Annals of Neurology, 67(3), 353–364.
29. Roe, C. M., Mintun, M. A., D'Angelo, G., Xiong, C., Grant, E. A., & Morris, J. C. (2008). Alzheimer disease and cognitive reserve: variation of education effect with carbon 11-labeled Pittsburgh compound B uptake. Archives of Neurology, 65(11), 1467–1471.
30. Rowe, C. C., Ellis, K. A., Rimajova, M., Bourgeat, P., Pike, K. E., Jones, G., et al. (2010). Amyloid imaging results from the Australian imaging, biomarkers and lifestyle (AIBL) study of aging. Neurobiology of Aging, 31(8), 1275–1283.
31. Ryan, J., & Paolo, A. (1992). A screening procedure for estimating premorbid intelligence in the elderly. The Clinical Neuropsychologist, 6, 53–62.
32. Scarmeas, N., Zarahn, E., Anderson, K. E., Habeck, C. G., Hilton, J., Flynn, J., et al. (2003). Association of life activities with cerebral blood flow in Alzheimer disease: implications for the cognitive reserve hypothesis. Archives of Neurology, 60(3), 359–365.
33. Scarmeas, N., Luchsinger, J. A., Schupf, N., Brickman, A. M., Cosentino, S., Tang, M. X., et al. (2009). Physical activity, diet, and risk of Alzheimer disease. JAMA, 302(6), 627–637.
34. Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., et al. (2011a). Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement, 7(3), 280–292.
35. Sperling, R. A., Jack Jr., C. R., & Aisen, P. S. (2011b). Testing the right target and right drug at the right stage. Science Translational Medicine, 3(111), 111 cm133.
36. Stern, Y. (2009). Cognitive reserve. Neuropsychologia, 47(10), 2015–2028.
37. Stern, Y. (2012). Cognitive reserve in ageing and Alzheimer's disease. Lancet Neurology, 11(11), 1006–1012.
38. Stern, Y., Alexander, G. E., Prohovnik, I., & Mayeux, R. (1992). Inverse relationship between education and parietotemporal perfusion deficit in Alzheimer's disease. Annals of Neurology, 32, 371–375.
39. Stern, Y., Alexander, G. E., Prohovnik, I., Stricks, L., Link, B., Lennon, M. C., et al. (1995). Relationship between lifetime occupation and parietal flow: implications for a reserve against Alzheimer's disease pathology. Neurology, 45, 55–60.
40. Sumowski, J. F., Chiaravalloti, N., & DeLuca, J. (2009). Cognitive reserve protects against cognitive dysfunction in multiple sclerosis. Journal of Clinical and Experimental Neuropsychology, 31(8), 913–926.
41. Wilson, R. S., Bennett, D. A., Bienias, J. L., Mendes de Leon, C. F., Morris, M. C., & Evans, D. A. (2003a). Cognitive activity and cognitive decline in a biracial community population. Neurology, 61(6), 812–816.
42. Wilson, R., Barnes, L., & Bennett, D. (2003b). Assessment of lifetime participation in cognitively stimulating activities. Journal of Clinical and Experimental Neuropsychology, 25(5), 634–642.
43. Wilson, R. S., Scherr, P. A., Schneider, J. A., Tang, Y., & Bennett, D. A. (2007). Relation of cognitive activity to risk of developing Alzheimer disease. Neurology, 69(20), 1911–1920.
44. Wirth, M., Villeneuve, S., La Joie, R., Marks, S. M., & Jagust, W. J. (2014). Gene–environment interactions: lifetime cognitive activity, APOE genotype, and beta-amyloid burden. The Journal of Neuroscience, 34(25), 8612–8617.
45. Wolk, D. A., Price, J. C., Madeira, C., Saxton, J. A., Snitz, B. E., Lopez, O. L., et al. (2012). Amyloid imaging in dementias with atypical presentation. Alzheimers Dement, 8(5), 389–398.